Jan Freark de Boer (Jan F de Boer)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Topics

Cardiovascular Risk Factors

Top Venues

International journal of molecular sciences

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Willemien F J Hof, Jan Freark de Boer, Henkjan J Verkade
Emerging drugs for the treatment of progressive familial intrahepatic cholestasis: a focus on phase II and III trials. Expert opinion on emerging drugs (2024)
Sebastian Hendrix, Jenina Kingma, Roelof Ottenhoff, Masoud Valiloo, Monika Svecla, Lobke F Zijlstra, Vinay Sachdev, Kristina Kovac, Johannes H M Levels, Aldo Jongejan, Jan Freark de Boer, Folkert Kuipers, Antoine Rimbert, Giuseppe Danilo Norata, Anke Loregger, Noam Zelcer
Hepatic SREBP signaling requires SPRING to govern systemic lipid metabolism in mice and humans. Nature communications 14 (1) (2023)
Jiufang Yang, Theo H van Dijk, Martijn Koehorst, Rick Havinga, Jan Freark de Boer, Folkert Kuipers, Tim van Zutphen
Intestinal Farnesoid X Receptor Modulates Duodenal Surface Area but Does Not Control Glucose Absorption in Mice. International journal of molecular sciences 24 (4) (2023)
Jiufang Yang, Theo H van Dijk, Martijn Koehorst, Rick Havinga, Jan Freark de Boer, Folkert Kuipers, Tim van Zutphen
Intestinal Farnesoid X Receptor Modulates Duodenal Surface Area but Does Not Control Glucose Absorption in Mice. International journal of molecular sciences 24 (4) (2023)
Jiufang Yang, Theo H van Dijk, Martijn Koehorst, Rick Havinga, Jan Freark de Boer, Folkert Kuipers, Tim van Zutphen
Intestinal Farnesoid X Receptor Modulates Duodenal Surface Area but Does Not Control Glucose Absorption in Mice. International journal of molecular sciences 24 (4) (2023)
Anna Palmiotti, Hilde D de Vries, Milaine V Hovingh, Martijn Koehorst, Niels L Mulder, Esther Verkade, Melany K Veentjer, Theo H van Dijk, Vincent W Bloks, Rick Havinga, Henkjan J Verkade, Jan Freark de Boer, Folkert Kuipers
Bile Acid Sequestration via Colesevelam Reduces Bile Acid Hydrophobicity and Improves Liver Pathology in Cyp2c70 -/- Mice with a Human-like Bile Acid Composition. Biomedicines 11 (9) (2023)
Jiufang Yang, Theo H van Dijk, Martijn Koehorst, Rick Havinga, Jan Freark de Boer, Folkert Kuipers, Tim van Zutphen
Intestinal Farnesoid X Receptor Modulates Duodenal Surface Area but Does Not Control Glucose Absorption in Mice. International journal of molecular sciences 24 (4) (2023)
Jiufang Yang, Theo H van Dijk, Martijn Koehorst, Rick Havinga, Jan Freark de Boer, Folkert Kuipers, Tim van Zutphen
Intestinal Farnesoid X Receptor Modulates Duodenal Surface Area but Does Not Control Glucose Absorption in Mice. International journal of molecular sciences 24 (4) (2023)
Yared Paalvast, Enchen Zhou, Yvonne J W Rozendaal, Yanan Wang, Albert Gerding, Theo H van Dijk, Jan Freark de Boer, Patrick C N Rensen, Ko Willems van Dijk, Jan A Kuivenhoven, Barbara M Bakker, Natal van Riel, Albert K Groen
A Systems Analysis of Phenotype Heterogeneity in APOE*3Leiden.CETP Mice Induced by Long-Term High-Fat High-Cholesterol Diet Feeding. Nutrients 14 (22) (2022)
Vinay Sachdev, Madalina Duta-Mare, Melanie Korbelius, Nemanja Vujic, Christina Leopold, Jan Freark de Boer, Silvia Rainer, Peter Fickert, Dagmar Kolb, Folkert Kuipers, Branislav Radovic, Gregor Gorkiewicz, Dagmar Kratky
Impaired Bile Acid Metabolism and Gut Dysbiosis in Mice Lacking Lysosomal Acid Lipase. Cells 10 (10) (2021)
Boyan Zhang, Folkert Kuipers, Jan Freark de Boer, Jan Albert Kuivenhoven
Modulation of Bile Acid Metabolism to Improve Plasma Lipid and Lipoprotein Profiles. Journal of clinical medicine 11 (1) (2021)
Wijtske Annema, Jan Freark de Boer, Arne Dikkers, Lidiya G Dimova, Markus van der Giet, Stephan J L Bakker, Uwe J F Tietge
Group IIA Secretory Phospholipase A2 Predicts Graft Failure and Mortality in Renal Transplant Recipients by Mediating Decreased Kidney Function. Journal of clinical medicine 9 (5) (2020)